Company intelligence / Profile preview

KT&G

Seoul, Seoul Special City, South Koreaen.ktng.com ↗

Ownership: Public · 033780
Development stage: Commercial

Overview

KT&G Life Sciences is a South Korean biopharmaceutical company focused on innovative drug R&D. It was spun off from the larger conglomerate KT&G Corporation, which is best known globally for tobacco and ginseng products but has diversified into pharmaceuticals and biotechnology through subsidiaries like KT&G Life Sciences. The company’s pipeline includes several preclinical or early-stage drug candidates targeting inflammation, obesity, prostatitis, and xerophthalmia. No clinical results or approved drugs have been reported as of April 2025.

Therapeutic areas: EndocrinologyOphthalmologyImmunologyMen's Health
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

KL-7016

Beyond the preview

Go deeper on KT&G.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KT&G.

Explore the full profile